Biomea Fusion (BMEA) Change in Acquisitions & Divestments (2021 - 2023)
Biomea Fusion (BMEA) posted Change in Acquisitions & Divestments of $1.2 million for Q1 2023, up 10354.55% sequentially from $11000.0 in Q4 2022, and down 94.4% YoY from $20.5 million in Q1 2022.
Biomea Fusion (BMEA) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
Biomea Fusion has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $1.2 million in Q1 2023.
- Quarterly Change in Acquisitions & Divestments fell 94.4% year-over-year to $1.2 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $1.2 million (down 95.95% YoY) and the FY2023 annual result came in at $1.2 million, down 95.95% from the prior year.
- Change in Acquisitions & Divestments improved to $1.2 million in Q1 2023 per BMEA's latest filing, from $11000.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $20.5 million in Q1 2022 and troughed at $11000.0 in Q4 2022.
- A 3-year average of $5.2 million and a median of $2.0 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 91.09% in 2022, down 99.77% in 2022.
- Over 3 years, Change in Acquisitions & Divestments stood at $4.8 million in 2021, then plunged by 99.77% to $11000.0 in 2022, then jumped by 10354.55% to $1.2 million in 2023.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $1.2 million, $11000.0, and $175000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 11,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 7.65 Mn |
| Jun 30, 2022 | 7.65 Mn |
| Mar 31, 2022 | 20.54 Mn |
| Mar 31, 2022 | 20.54 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Sep 30, 2021 | 1.97 Mn |
| Sep 30, 2021 | 1.97 Mn |